Member list of California Life Sciences Association

Below you find a list of all members of CLSA in alphabetical order.

Results 281 - 300 out of 950 displayed.
 
Sort direction:
Sort direction:
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14 15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48 »
Cytokinetics, Incorporated   
South San Francisco, USA
Cytokinetics is a biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. Cytokinetics’ MYQORZO® (aficamten) is a cardiac myosin inhibitor approved in the U.S., China, Europe and the UK for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). Following positive topline results...
CytomX Therapeutics, Inc.   
South San Francisco, USA
CytomX is a clinical-stage, oncology-focused biopharmaceutical company focused on developing novel conditionally activated, masked PROBODY® therapeutics designed to be localized to the tumor microenvironment. CytomX’s robust and differentiated pipeline comprises therapeutic candidates across multiple treatment modalities including antibody-drug conjugates (“ADCs”), cytokines and T-cell engagers. CytomX’s clinical-stage pipeline includes varsetatug masetecan (Varseta-M; CX-2051) and...
D&P Bioinnovations, Inc.   
San Diego, USA
D&P Bioinnovations, Inc. is a regenerative medicine company focused on repairing damaged organs with unique biomaterials and immunomodulatory stem cell factors. The company's first commercial therapeutic application for the implant is to regenerate a damaged esophagus to treat esophageal cancer and other sever ailments of the esophagus (i.e., Advanced Barrett's, GERD, pediatric atresia, physical trauma, etc.)
Danforth Health   
Waltham, USA
Danforth Health is a life sciences services and consulting platform that provides integrated operational and strategic support to biotechnology, pharmaceutical, medical device, and other life science companies. Its services span finance and human resources, investor and public relations, discovery and development, regulatory affairs, clinical operations, commercial and marketing, market access, and market research and analytics. The company supports clients across the corporate and product lifecycle,...
Daré Bioscience, Inc.   
San Diego, USA
Daré Bioscience, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of therapeutics, medical devices, and consumer health products for women’s health indications. The company’s pipeline spans reproductive health, contraception, vaginal health, sexual health, fertility, menopause, and infectious diseases, and includes both pharmaceutical and device-based product candidates under clinical and commercial development.
Daybreak Labs   
Livermore, USA
Daybreak Labs is an incubator for seed stage life sciences and hard technology startups. Daybreak Labs provides research and development capabilities, office space, and a community of scientists, engineers, and entrepreneurs to help speed the time to market for their startups.
DC3 Therapeutics   
South San Francisco, USA
DC3 Therapeutics is a full service Contract Research Organization (CRO). The company offers a full set of services necessary for drug development. The company supports Pre-Clinical and IND Enabling studies. The company's services include histology, in vitro pharmacology and ADME; as well as molecular, cellular and micro-biology.
Deciduous Therapeutics   
San Francisco, USA
Deciduous Therapeutics Inc. is an early-stage biotechnology company developing immune-based therapies targeting senescent cells. Its approach harnesses the immune system, particularly invariant natural killer T (iNKT) cells, to identify and eliminate pathogenic senescent cells associated with age-related diseases. The company focuses on therapeutic applications of cellular senescence and immune surveillance.
Deepcell, Inc.   
Menlo Park, USA
Deepcell, Inc. offers an AI-powered imaging and microfluidics platform that identifies and isolates viable cells based on morphological distinctions for use in translational research, diagnostic testing, and therapeutics. The company's mission is to enable novel biological insights at the single-cell level for improved diagnosis and treatment of disease.
DelNova, Inc.   
San Diego, USA
DelNova, Inc. is a privately held biopharmaceutical company developing innovative therapeutics using clinically validated molecules linked to advances in drug delivery to solve unmet medical needs. The company's lead clinical candidate, ReViVox®, is designed to rescue complications caused by off-target muscle paralysis following aesthetic and medical neurotoxin therapies, specifically botulinum toxins type A (e.g., Botox®). DelNova is resolving complications arising from botulinum toxin therapies...
Deloitte   
San Francisco, USA
Deloitte provides audit, consulting, financial advisory, risk management, and tax services to selected clients.
Delpor, Inc.   
Brisbane, USA
Delpor, Inc. is a clinical-stage biotechnology company developing long-acting implantable therapies for the treatment of chronic diseases. The company focuses on drug-device combination products designed to provide sustained drug release for up to one year from a small subcutaneous implant. Delpor’s proprietary technology platforms include PROZOR™, a formulation system enabling controlled release of poorly soluble drugs, and NANOPOR™, a nanoporous membrane technology designed to achieve...
Demetrix, Inc.   
Berkeley, USA
Demetrix, Inc. manufactures natural medicines using synthesis biology. The company uses genetics and computing enabled deciphering technology to produce drugs. The company enables the refactoring biotechnology microbial hosts for gene synthesis.
Demonpore Inc.   
Richmond, USA
Demonpore Inc. is a biotechnology company which specializes in building mechanical nanopores to create a molecular sensing platform. The company builds mechanical, nanopore-based molecular sensors. Its core product, originally named the demonpore 64 and updated as the MR1 Molecular Streaming Device, is engineered as a molecular gaming console.
Denali Therapeutics Inc.   
San Francisco, USA
Denali Therapeutics Inc. is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's product Tividenofusp alfa (DNL310) is an investigational enzyme replacement therapy (ERT) designed to treat both the central nervous system (CNS) and peripheral manifestations of Hunter syndrome (MPS II). The company's other product, DNL126, is an investigational enzyme replacement therapy designed to cross the BBB for the potential...
Dendreon Pharmaceuticals LLC   
Seal Beach, USA
Dendreon is a commercial-stage immune cell therapy company. The firm's flagship product, PROVENGE® (sipuleucel-T), the FDA-approved cell therapy for solid tumors, leverages the innate strengths of personalized cell therapy made from a patient's immune cells and has been shown to prolong certain lives of men. The firm not only provides end-to-end development support for the cell therapy, but also provides manufacturing science, clinical, regulatory, and patient operation services.
Department of Neurological Surgery, University of California, San Francisco   
San Francisco, USA
The Department of Neurological Surgery at UCSF is dedicated to treating patients with neurosurgical disorders and to the search for better therapies and cures.
DermBiont, Inc.   
Boston, USA
DermBiont is a dermatology company leveraging skin microbiome therapeutics (live biotherapeutics) to treat the root cause of skin diseases. In addition to the company’s lead product in development to treat onychomycosis and atopic dermatitis, DBI-001, the company is advancing four other clinical assets across a wide range of skin diseases caused by a dysbiosis of the microbiome.
Dexcom, Inc.   
San Diego, USA
DexCom, Inc. develops, manufactures, and distributes continuous glucose monitoring (CGM) systems for diabetes management. The company's CGM systems provide an alternative to traditional blood glucose monitoring and are designed to integrate with insulin delivery systems, including automated insulin delivery solutions.
Diagnologix, LLC   
San Diego, USA
Diagnologix, LLC specializing in innovative cell-processing systems designed to sort, isolate, and manipulate rare cells like circulating tumor cells (CTCs), stem cells, and immune cells from biological fluids. The company's core technology uses lipid-shelled microbubbles to enable buoyancy-based cell separation and concentration. The BUBLES platform has been developed for applications including cell isolation, multi-marker cell sorting and the processing of hematopoietic stem cells and T cells....

«  1  2  3  4  5  6  7  8  9  10  11  12  13  14 15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48 »

Disclaimer: Any membership totals displayed reflect organizations who have agreed to display their membership information and may not be indicative of CLSA's total member population.

© Biotechgate by Venture Valuation